LongVentKids Study
LVK
Prolonged Mechanical Ventilation in Paediatric Intensive Care : An International Cross-Sectional Prevalence Study
1 other identifier
observational
6,000
1 country
1
Brief Summary
Scientific advances, population growth, lower mortality, and increasing complexity of diseases have boosted up the number of patients requiring prolonged breathing assistance with mechanical ventilators in the pediatric intensive care units (PICU) in many parts of the developed world. Previous studies also suggest that there is a small group of children who actually need such a high level of support for extended periods of time, utilizing a lot of human and technical resources. We defined children with prolonged mechanical ventilation (PMV) if they required supports with a breathing machine for more than 14 days. We propose an international point prevalence study of children requiring PMV in PICU. We will conduct the study in multiple centers in several different regions, including North and South America, Europe, and Asian countries, with a strong relationship with local physician colleagues. Practice for patients requiring PMV will be examined including the type and size of local PICU, admission and discharge policies, and patient and treatment modalities administered to such patients, types of professionals looking after patients in PMV, types of health care. We anticipate a high variability in practices suggesting a need to further standardize the management of PMV.. Specifically, as an immediate consequence, by comparing and understanding the differences in patient demographics, practice details among PICUs in regards to the background factors of local PICUs and their patients, practitioners will share their way of dealing with such patients. In that way, this study will support the need to generate guidelines and lead to patient care improvement in PICUs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 4, 2019
CompletedFirst Submitted
Initial submission to the registry
September 27, 2019
CompletedFirst Posted
Study publicly available on registry
October 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 4, 2022
CompletedOctober 2, 2019
September 1, 2019
2 years
September 27, 2019
September 30, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of PMV
number of patients meet PMV criteria devided by the number of patients admitted in PICUs on the specific data collection date and time.
eight times during two-year study period
Secondary Outcomes (2)
Patient and treatment demographics
eight times during two-year study period
Outcomes at 90days follow-up
90 days from the initial data collection
Interventions
No intervention will be applied in this study
Eligibility Criteria
All patients on invasive or non-invasive mechanical ventilation on the day of the study or patients who had been on InMV or non-invasive ventilation (NIVs) during their PICU stays will be eligible. Patients who fulfill inclusion criteria and do not meet any exclusion criteria will be considered for inclusion in the study.
You may qualify if:
- Patients who are ventilated \>14 consecutive days (after 37 weeks postmenstrual post-conception age)\*
- including for more than 6 hours per day including on InMV and NIV duration
- patient who have had and short interruptions (\<48hours) of ventilation during the weaning process as the same episode of ventilation can be included.
- InMV can be administered through an endotracheal tube or a tracheostomy tube.
- NIV can be managed through a nasal, full-face, total facial mask, or helmet.
- Patient on HFNC will be included as on respiratory support if they have a proper or a nasal cannula (that allows \>=1 liters/kg/min (LPM) and \>4LPM).
- We define nasal oxygen supply \<1 L/kg/min as non-NIV practice.
You may not qualify if:
- Age \>18 years
- Already included in this study
- No consent if required
- Brain death
- Premature children not yet at 37 weeks gestational age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Justine's Hospitallead
- Réseau en Santé Respiratoire du Québeccollaborator
- Fonds de la Recherche en Santé du Québeccollaborator
- Women and Children's Health Research Institute, Canadacollaborator
- Réseau mère-enfant de la francophoniecollaborator
Study Sites (1)
CHU Sainte Justine
Montreal, Quebec, H3T 1C5, Canada
Related Publications (1)
Kawaguchi A, Fernandez A, Baudin F, Chiusolo F, Lee JH, Brierley J, Colleti J Jr, Reiter K, Won Kim K, Lopez Fernandez Y, Kneyber M, Pons-Odena M, Napolitano N, Graham RJ, Kawasaki T, Garros D, Garcia Guerra G, Jouvet P; LongVentKids study group. Prevalence, management, health-care burden, and 90-day outcomes of prolonged mechanical ventilation in the paediatric intensive care unit (LongVentKids): an international, prospective, cross-sectional cohort study. Lancet Child Adolesc Health. 2025 Jan;9(1):37-46. doi: 10.1016/S2352-4642(24)00296-7.
PMID: 39701660DERIVED
Study Officials
- STUDY DIRECTOR
Philippe Jouvet, MD PhD MBA
St. Justine's Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoctoral Scholar
Study Record Dates
First Submitted
September 27, 2019
First Posted
October 2, 2019
Study Start
September 4, 2019
Primary Completion
September 3, 2021
Study Completion
September 4, 2022
Last Updated
October 2, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- After all the data collection completed, summarized de-identified study result will be shared with the participating centers. Patient individual data will be shared between the central coordinating center and the center where PI of ancillary and posthoc study belongs.
- Access Criteria
- All the study protocol and CRF will be shared with the participating centers.
Data sharing agreement will be mandatory to be signed between the central coordination center (CHU Sainte Justine) and the participating center.